The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain magnetic resonance imaging metrics related to remote head injury. This research aims to transform healthcare for Service Members, Veterans, and the general public by advancing scientific knowledge and potential new interventions for traumatic brain injury and associated conditions like dementia.
Generated 6/11/24, 4:32 AM